Metraipolis › archive › dc_fc553761643d

Trastuzumab-TKI combination in HER2-Positive tumors: a FAERS-Based safety profile and multimodal analysis of Tanespimycin's role in enhancing targeting of the… — Europe PMC PMID:42719185

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42719185
DOI
10.3389/fphar.2026.1844013
License (as archived)
solo-consultazione
Archived
2026-10-07T19:05:09.268Z
SHA-256 of the archived text
53dae62eb7f4cb3b4f8bba6be51996e21ff6eb9e04d24e0ebb721c6b0eb1e516
Stable URL of this page
https://metraipolis.com/documento/dc_fc553761643d

How to cite

Trastuzumab-TKI combination in HER2-Positive tumors: a FAERS-Based safety profile and multimodal analysis of Tanespimycin's role in enhancing targeting of the… — Europe PMC PMID:42719185 — Europe PMC (en), https://europepmc.org/article/MED/42719185 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc553761643d (Metraipolis archive dc_fc553761643d, sha256 53dae62eb7f4cb3b4f8bba6be51996e21ff6eb9e04d24e0ebb721c6b0eb1e516)
BibTeX
@misc{dcfc553761643d,
  title = {Trastuzumab-TKI combination in HER2-Positive tumors: a FAERS-Based safety profile and multimodal analysis of Tanespimycin's role in enhancing targeting of the… — Europe PMC PMID:42719185},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42719185},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc553761643d; sha256 53dae62eb7f4cb3b4f8bba6be51996e21ff6eb9e04d24e0ebb721c6b0eb1e516},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42719185. Agents can read the archived copy with the MCP tool read_document.